LQLin Qiu

Lin Qiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lin Qiu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Experiences and Factors Influencing the Transition to Adult Care in Adolescents With Inflammatory Bowel Disease: A Mixed‐Methods Systematic Review

    by Hui‐Qin Zhang, Jia‐Bin Xu, Lin Qiu, Yi‐Tian Gao, Si‐Qi Xie, Qian‐Yi Zhai, Lan‐Shu Zhou

    Aim: To synthesise the literature on factors influencing transition to adult care in adolescents with Inflammatory Bowel Disease (IBD). Background: Adolescents with IBD often experience care fragmentation and disease exacerbation during the transition to adult care. However, there is a scarcity of systematic reviews that synthesise the multidimensional factors influencing transition in adolescents with IBD. Design: This was a mixed‐methods systematic review using the convergent integrated analysis framework. Methods: A mixed‐methods systematic review was conducted on August 11, 2026. A computerised search was conducted in PubMed, Embase, Web of Science, CINAHL, ProQuest, Scopus, Cochrane Library, VIP Database, Wanfang Database, China National Knowledge Infrastructure (CNKI) and the Chinese Biomedical Literature Database (CBM), and the reference lists of the included studies were also screened. The quality of the included studies was assessed using the MMAT. Data were extracted from the selected articles and synthesised using a convergent‐integrated approach. Results: A total of 41 articles that met the screening criteria were rigorously reviewed and included in this systematic review. Guided by the SMART model, this synthesis of 41 studies identified two themes and 10 sub‐themes influencing transitional care among adolescents with IBD: pre‐existing objective factors (socio‐demographics/culture, access/insurance, health status/risk), and modifiable subjective variables (developmental maturity, knowledge, skills/efficacy, beliefs/expectations, goals, relationships, psychosocial functioning). Conclusion: Guided by the SMART model, this systematic review synthesised factors influencing transition‐care outcomes among adolescents with IBD from the perspectives of patients, caregivers and healthcare providers, offering guidance for the subsequent development of more individualised transition programmes. Relevance to Clinical Practice: Mapping evidence to the SMART transition model enables identification of at‐risk adolescents for early, intensive family‐involved transition, with modifiable subjective variables serving as intervention targets for individualised care. Reporting Method: This review followed the PRISMA 2020 guidelines. Patient or Public Contribution: No.

  • Open Access

    Comparative Effectiveness of Noninvasive Brain-Computer Interface–Based Interventions for Upper Limb Rehabilitation in Poststroke Hemiplegia: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

    by Jiabin Xu, Yitian Gao, Siqi Xie, Weikang Jiang, Huiqing Zhang, Lin Qiu, Mengxue Jiang, Lanshu Zhou

    Background: Noninvasive brain-computer interface (BCI)–based interventions show promise for poststroke motor recovery. However, the intrinsic complexity of BCI-based interventions limits the determination of their comparative efficacy. Objective: Guided by the International Classification of Functioning, Disability and Health framework, this review evaluated the effectiveness of BCI-based interventions in poststroke upper limb rehabilitation and identify the optimal intervention. Methods: We searched PubMed, Cochrane Library, EBSCOhost, Web of Science, Embase, Wiley Online Library,CNKI, Wanfang, VIP, and SinoMed through July 2026. Randomized controlled trials (RCTs) assessing BCI-based interventions for poststroke upper limb rehabilitation were included. Outcomes were body functions and structures (Fugl-Meyer Assessment of Upper Extremity [FMA-UE]) and activities and participation (Action Research Arm Test [ARAT], Wolf Motor Function Test [WMFT], and Modified Barthel Index [MBI]). Risk of bias was assessed using Cochrane RoB 2, and evidence quality was graded using the Grading of Recommendations, Assessment, Development, and Evaluation framework. We used pairwise meta-analyses to evaluate the overall effectiveness of BCI-based interventions vs controls and network meta-analysis to compare the interventions. Results: Seventy-two RCTs involving 2906 patients with stroke were included, evaluating 12 BCI-based interventions. Pairwise meta-analyses demonstrated that, compared with control groups, BCI-based interventions improved FMA-UE (mean difference [MD] 5.33, 95% CI 4.28 to 6.38; 95% prediction interval [PI] −1.76 to 12.43), ARAT (MD 5.26, 95% CI 3.90 to 6.62; 95% PI 0.41 to 10.11), WMFT (MD 7.25, 95% CI 5.06 to 9.44; 95% PI 0.71 to 13.79), and MBI (MD 8.18, 95% CI 6.04 to 10.32; 95% PI −1.87 to 18.23). Network meta-analysis revealed that BCI-motor imagery-transcutaneous electrical acupoint stimulation (BCI-MI-TEAS) achieved the highest surface under the cumulative ranking curve (SUCRA; 95.5%) in improving FMA-UE. For ARAT, BCI-MI–end-effector robots and transcranial direct current stimulation (tDCS; 86.3%) alongside BCI-MI-TEAS (86.3%) yielded the highest SUCRA. BCI-MI–exoskeleton robot showed the highest SUCRA for WMFT (92.7%), whereas BCI-MI-TEAS (85.3%) and BCI-MI–exoskeleton robot (81.7%) ranked highest for MBI. The evidence quality ranged from very low to high across these interventions. Conclusions: This study represents the first network meta-analysis comparing the efficacy of different BCI-based interventions. Unlike previous reviews, interventions were categorized by experimental paradigms, external feedback devices, and adjunctive noninvasive brain stimulation, to enable clinically meaningful comparisons. Overall, BCI-based interventions significantly improved poststroke upper limb rehabilitation. Among evaluated interventions, BCI-MI-TEAS demonstrated the most performance across body functions, structures, and activities and participation, whereas BCI-MI–end-effector robot + tDCS showed advantages for fine motor dexterity and BCI-MI–exoskeleton robot improved activities of daily living.Given low to moderate evidence certainty and substantial heterogeneity, these findings remain exploratory. High-quality trials are needed to establish the clinical utility of these interventions.

  • Open Access

    Comparison of the effects of different functional exercise sequences on lymphedema in breast cancer: protocol for an exploratory randomised controlled cross-over trial

    by Lin Qiu, Jing Wu, Yingying Huang, Maodie Ye, Lifang Song, Haihong Huang, Yongmei Jin

    Introduction Breast cancer-related lymphedema (BCRL) is a common postoperative complication of breast cancer. It develops in a chronic and vicious cycle. Once lymphedema occurs, it cannot be cured and bring serious physiological, psychological, social and economic burden to patients. Upper limb functional exercises are an effective and convenient intervention for managing lymphedema. However, the optimal exercise sequence remains unclear. Therefore, we aim to compare the effects of exercise sequences under the guidance of commonly used exercise sequences and lymphatic flow theory. Methods An exploratory randomised controlled cross-over trial will be conducted. 32 patients with BCRL are randomly allocated into two groups (group A and group B). Group A patients will perform functional exercise from wrist joint to shoulder joint, and the exercise direction of group B is opposite to that of group A, that is, from shoulder joint to wrist joint end. Exercise time is once a day, each 20–30 min, for 2 weeks. After 2 weeks of washout period, A and B groups of exchange exercise sequences (exercise frequency and duration unchanged). The primary outcome is upper limb circumference, and secondary outcomes are upper limb function and lymphedema symptoms. Ethics and dissemination This study protocol is presented in accordance with the Standard Protocol Items: Recommendations for Interventional Trials guidelines. All participants will sign a written informed consent. The research ethics regional committee of Shanghai Seventh People’s Hospital has approved the study. Regardless of the outcome of this study, the results will be published in open-access journals to ensure public access. Trial registration number ChiCTR2200066463.

  • Open Access

    CAPRIN2 upregulation by LINC00941 promotes nasopharyngeal carcinoma ferroptosis resistance and metastatic colonization through HMGCR

    by Lin Qiu, Rui Zhou, Ling Zhou, Shiping Yang, Jiangxue Wu

    Distant metastasis is the main cause of death in nasopharyngeal carcinoma (NPC) patients. There is an urgent need to reveal the underlying mechanism of NPC metastasis and identify novel therapeutic targets. The ferroptosis resistance and survival ability of extracellular matrix (ECM)-detached tumor cells are important factors in determining the success of distant metastasis. In this study, we found that CAPRIN2 contributes to the ferroptosis resistance and survival of ECM-detached NPC cells. Moreover, CAPRIN2 serves as a positive regulator of NPC cell migration and invasion. HMGCR, the key metabolic enzyme of the mevalonate pathway, was identified as the key downstream molecule of CAPRIN2, which mediates its regulation of ferroptosis, survival, migration and invasion of NPC cells. Lung colonization experiments showed that downregulation of the CAPRIN2/HMGCR axis resulted in reduced lung metastasis of NPC cells. Erastin treatment inhibited the ability of NPC cells to colonize the lungs, which was further enhanced by CAPRIN2/HMGCR axis downregulation. Regulated by upstream LINC00941, CAPRIN2 is abnormally activated in NPC, and its high expression is associated with a poor prognosis. In conclusion, CAPRIN2 is a molecular marker of a poor prognosis in NPC, and the LINC00941/CAPRIN2/HMGCR axis provides a new target for the treatment of NPC metastasis and ferroptosis resistance.